Tuesday, March 17, 2026

Telegram’s Founder Says No to EU Censorship Demands

Pavel Durov defends free speech against EU censorship demands, emphasizing democracy and individual autonomy amid political pressures.

Biosimilar Red Tape Showdown: Patient Groups and Insurers Push Congress to End “Interchangeability” Rules After $56B in Savings

U.S. groups urge Congress to eliminate biosimilar interchangeability regulations, boosting access and reducing costs for Korean firms.

HLB Therapeutics CEO: New Eye Drop Could Disrupt the Market for Rare Corneal Disease

HLB Therapeutics CEO anticipates RGN-259 could surpass Oxervate within 3 years as a simpler, cost-effective NK treatment.

Tag: An Yujin

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.